Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Aug 19;112(1):188–196. doi: 10.1016/j.ijrobp.2021.08.017

Table 1.

Patient and treatment characteristics

Characteristic All patients Patients without
symptomatic
cardiac events
Patients with
symptomatic
cardiac events
No. 109 83 26
Median age (range, years) 58 (36-82) 57 (39-82) 62 (36-81)
Gender
 Male 60 (59%) 43 (52%) 17 (65%)
 Female 49 (41%) 40 (48%) 9 (35%)
Tumor laterality
 Right 64 (59%) 47 (57%) 17 (65%)
 Left 45 (41%) 36 (43%) 9 (35%)
Stage
 IIIA 64 (59%) 47 (57%) 17 (65%)
 IIIB 45 (41%) 36 (43%) 9 (35%)
ECOG Performance status
 0 70 (64%) 50 (60%) 20 (77%)
 1 39 (36%) 33 (40%) 6 (23%)
Active/former smoker
 No 15 (14%) 13 (16%) 2 (8%)
 Yes 94 (86%) 70 (84%) 24 (92%)
Median pack years (range) 37 (5-120) 35 (13-120) 43 (5-100)
WHO/ISH 10-yr risk
 <10 % 65 (60%) 54 (65%) 11 (42%)
 10-20 % 34 (31%) 22 (27%) 12 (46%)
 ≥20 % 10 (9%) 7 (8%) 3 (12%)
CAD
 No 93 (85%) 76 (92%) 17 (65%)
 Yes 16 (15%) 7 (8%) 9 (35%)
Calcifications
 None 45 (41%) 42 (51%) 3 (12%)
 Low (<0.2 cc) 31 (28%) 22 (27%) 9 (35%)
 High (≥0.2 cc) 33 (30%) 19 (23%) 14 (54%)
Prescribed RT dose
 70-74 Gy 84 (77%) 65 (78%) 19 (73%)
 78-90 Gy 25 (23%) 18 (22%) 7 (27%)
Gross tumor volume (median) 46.1 cc 47.1 cc 44.5 cc
Heart mean dose (median) 12.4 Gy 10.1 Gy 20.4 Gy
Heart V5Gy (median) 37.6 % 34.1 % 55.9 %
Heart V30Gy (median) 17.4 % 12.1 % 28.8 %
Left ventricle mean dose (median) 4.0 Gy 2.9 Gy 9.5 Gy
Left ventricle V5Gy (median) 18.4 % 14.2 % 38.2 %
Left ventricle V30Gy (median) 2.0 % 0.4 % 10.3 %

Abbreviations: ECOG, Eastern Cooperative Oncology Group; WHO/ISH, World Health Organization / International Society of Hypertension; CAD, coronary artery disease; RT, radiotherapy; V5Gy, volume receiving ≥5 Gy; V30Gy, volume receiving ≥30 Gy.

*

Column percentages displayed.